The US decision could affect the production of the corona vaccine 'Covidshield' in the country.

New delhi date. 08 March 2021, Monday

Running in the country could hit the corona vaccination process. Shortage of raw material may affect the production of vaccines being developed from Serum Institute of India. The production of Covidshield depends on raw materials from the United States and the United States has recently banned the supply of raw materials. However this is not a permanent ban.

Adar Poonawala, CEO of the Pune-based Serum Institute of India, which supplies 80% of the world's vaccines, has questioned the sanctions imposed by the United States. He said in a discussion session organized by the World Bank that the sanctions imposed by the United States could cause many problems in the coming days. American law banning the export of important goods such as bags and filters could pose a serious crisis.

According to media reports, concerns over supply cuts have been heightened by the announcement of the use of the US Defense Production Act. The U.S. government wants to use the act to increase the supply needed to make Pfizer vaccines. It is worth mentioning that Pfizer reduced its production last year. When the company faced a shortage of raw materials.

Punawala said that in this time of Korona epidemic where every country is moving forward with the cooperation of each other. The US decision could be very detrimental as the Serum Institute of India is also working day and night to meet the needs of many countries.